Skip to main content
Netherlands News in English

Main navigation

  • Top stories
  • Health
  • Crime
  • Politics
  • Business
  • Tech
  • Culture
  • Sports
  • Weird
  • 1-1-2
Image
Amsterdam UMC
Amsterdam UMC, a hospital in Amsterdam-Zuidoost - Credit: cakifoto / DepositPhotos - License: DepositPhotos
Health
Amsterdam UMC
Radboudumc
depression
antidepressants
sertraline
zoloft
AI
algorithm
Eric Ruhe
Liesbeth Reneman
Sunday, 11 February 2024 - 07:15

Share this article:

Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window Opens in a new window

AI technique can determine if antidepressants are working after one week

It is well known that the commonly used antidepressant sertraline, better known under the brand name Zoloft, works well for some and not at all for others. An AI algorithm developed by researchers at Amsterdam UMC and Radboudumc in Nijmegen can now help doctors determine after a week whether a patient is sensitive to the drug, instead of the typical six to eight weeks of trial and error, the university hospitals announced.

The AI algorithm predicts whether the antidepressant will work based on a brain scan and an individual's clinical information. The researchers tested their algorithm by seeing whether they could predict the effect of sertraline in a previous study conducted in the United States.

In that study, 229 patients with severe depression underwent MRI scans and had their clinical data recorded before and after a week of treatment with sertraline or a placebo. The Dutch researchers’ algorithm could predict that sertraline would work for only a third of the patients in that study.

“The algorithm suggested that those who had a lot of blood flow in the anterior cingulate cortex, the area of the brain involved in emotion regulation, would be helped by the drug,” said Eric Ruhé, a psychiatrist at Radboudumc. That turned out to be the case at the second measurement, a week after the patients started taking the antidepressant, based on the severity of their symptoms

Sertraline is one of the most prescribed antidepressants in Europe and the United States. In the Netherlands, some 126,000 people use it. “With this method, we can already prevent two-thirds of the number of ‘erroneous’ prescriptions of sertraline and thus offer better quality of care for the patient,” said Liesbeth Reneman, professor of Neuroradiology at Amsterdam UMC.

The researchers hope that their method can help better tailor sertraline treatment to the individual patient. “Currently, there is no exact science. The patient is given the medication, and after six to eight weeks - in practice, often up to six months - it is checked whether it works. If the symptoms do not subside, the patient is given another antidepressant, and this process can repeat itself several times,” Amsterdam UMC said.

All that time, the patient is still struggling with their depression symptoms, combined with side effects from antidepressants, which can include nausea, dizziness, insomnia, and sexual dysfunction, among other things.

The results of the study are published in the American Journal of Psychiatry. The researchers hope their method can eventually also help test the effectiveness of other antidepressants.

More like this

Image
Gurneys in a hospital corridor
Societal change behind increase in euthanasia; Doctors experience more pressure
Image
An Uber driver
Mass claim: Uber's AI-driven pay system cut drivers' income while boosting profits
Image
Amsterdam UMC
Women more likely than men to struggle with anxiety, depression after cardiac arrest
Image
Data privacy
Discriminating algorithms still a big problem in Netherlands, privacy watchdog says
Make NL Times your top Google source

Follow us:

Latest stories

  • What international businesses should know about sea freight
  • Locals in Reeuwijk paint zebra crossing for ducklings that cross the road daily
  • Mugwort pollen set to drive hay fever symptoms across the Netherlands
  • Court: Dutch Cabinet was allowed to ban U.S. takeover of DigiD firm Solvinity
  • “Like a landlord upending your furniture”: The shocking truth about who owns your AI data

Top stories

  • Court: Dutch Cabinet was allowed to ban U.S. takeover of DigiD firm Solvinity
  • OLVG hospital in Amsterdam starts trial with late abortions
  • One killed in stabbing on Roermond street; Suspect arrested
  • Netherlands to start military exercises with Ukraine, help design new air defense system
  • Ter Apel asylum center area declared safety risk zone after recent stabbings, fights

© 2012-2026, NL Times, All rights reserved.

Footer menu

  • Change Privacy Settings
  • Privacy Policy
  • Contact
  • Partner Content